The antitumor efficacy of docetaxel is enhanced by encapsulation in novel amphiphilic polymer cholesterol-coupled tocopheryl polyethylene glycol 1000 succinate micelles

[1]  Li Ni,et al.  Vitamin E TPGS modified liposomes enhance cellular uptake and targeted delivery of luteolin: An in vivo/in vitro evaluation. , 2016, International journal of pharmaceutics.

[2]  Senshang Lin,et al.  Effect of process and formulation variables on the preparation of parenteral paclitaxel-loaded biodegradable polymeric nanoparticles: A co-surfactant study , 2016 .

[3]  Xinyuan Zhu,et al.  A small molecule nanodrug consisting of amphiphilic targeting ligand-chemotherapy drug conjugate for targeted cancer therapy. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[4]  Minshan Chen,et al.  The clinical significance of preoperative serum cholesterol and high-density lipoprotein-cholesterol levels in hepatocellular carcinoma , 2016, Journal of Cancer.

[5]  Preeti Kumari,et al.  Recent advances in polymeric micelles for anti-cancer drug delivery. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[6]  Wim E Hennink,et al.  Complete Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel via Π-Π Stacking Stabilized Polymeric Micelles. , 2015, ACS nano.

[7]  H. Maeda,et al.  Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls , 2015, Expert opinion on drug delivery.

[8]  S. Prodduturi,et al.  Development of an antifungal denture adhesive film for oral candidiasis utilizing hot melt extrusion technology , 2015, Expert opinion on drug delivery.

[9]  Prakash Khadka,et al.  Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution and bioavailability , 2014 .

[10]  Xinrong Liu,et al.  Self-assembled micelles of novel amphiphilic copolymer cholesterol-coupled F68 containing cabazitaxel as a drug delivery system , 2014, International journal of nanomedicine.

[11]  F. Liu,et al.  Vitamin E reverses multidrug resistance in vitro and in vivo. , 2013, Cancer letters.

[12]  Zhiping Zhang,et al.  The applications of Vitamin E TPGS in drug delivery. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[13]  P. G. Frank,et al.  Cholesterol and breast cancer development. , 2012, Current opinion in pharmacology.

[14]  Yitao Wang,et al.  Polymeric micelles drug delivery system in oncology. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[15]  Yi Yan Yang,et al.  The use of cholesterol-containing biodegradable block copolymers to exploit hydrophobic interactions for the delivery of anticancer drugs. , 2012, Biomaterials.

[16]  Lin Mei,et al.  Novel docetaxel-loaded nanoparticles based on PCL-Tween 80 copolymer for cancer treatment , 2011, International journal of nanomedicine.

[17]  Si-Shen Feng,et al.  Formulation of Docetaxel by folic acid-conjugated d-α-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS(2k)) micelles for targeted and synergistic chemotherapy. , 2011, Biomaterials.

[18]  Kit S Lam,et al.  The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. , 2011, Biomaterials.

[19]  Vladimir Torchilin,et al.  Tumor delivery of macromolecular drugs based on the EPR effect. , 2011, Advanced drug delivery reviews.

[20]  Kazuo Maruyama,et al.  Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. , 2011, Advanced drug delivery reviews.

[21]  R. Mumper,et al.  Nanomedicinal strategies to treat multidrug-resistant tumors: current progress. , 2010, Nanomedicine.

[22]  P. Lai,et al.  Reversal of multidrug resistance using poly(L-lactide)-vitamin E TPGS micelles in breast cancer cell , 2009, 2009 International Conference on Biomedical and Pharmaceutical Engineering.

[23]  M. Sadoqi,et al.  Investigation of the micellar properties of the tocopheryl polyethylene glycol succinate surfactants TPGS 400 and TPGS 1000 by steady state fluorometry. , 2009, Journal of colloid and interface science.

[24]  Warren C W Chan,et al.  Mediating tumor targeting efficiency of nanoparticles through design. , 2009, Nano letters.

[25]  T. Anchordoquy,et al.  Cholesterol domains in cationic lipid/DNA complexes improve transfection. , 2008, Biochimica et biophysica acta.

[26]  F. Domann,et al.  α-Tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II , 2008, Oncogene.

[27]  Jie Pan,et al.  Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles. , 2008, Biomaterials.

[28]  Dasheng Wang,et al.  α-Tocopheryl Succinate Induces Apoptosis in Prostate Cancer Cells in Part through Inhibition of Bcl-xL/Bcl-2 Function* , 2006, Journal of Biological Chemistry.

[29]  E. Sausville,et al.  Contributions of human tumor xenografts to anticancer drug development. , 2006, Cancer research.

[30]  M. Wempe,et al.  Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[31]  T. Whiteside,et al.  Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention. , 2006, Seminars in cancer biology.

[32]  Afsaneh Lavasanifar,et al.  Polymeric micelles for drug delivery , 2006, Expert opinion on drug delivery.

[33]  V. Torchilin,et al.  Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and d-alpha-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin. , 2005, International journal of pharmaceutics.

[34]  M. Cruz,et al.  Permeabilisation and solubilisation of soybean phosphatidylcholine bilayer vesicles, as membrane models, by polysorbate, Tween 80. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[35]  So H. Kim,et al.  Enhanced anticancer efficacy of α-tocopheryl succinate by conjugation with polyethylene glycol , 2005 .

[36]  M. Varma,et al.  Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[37]  J. Neuzil,et al.  Vitamin E succinate and cancer treatment: a vitamin E prototype for selective antitumour activity , 2003, British Journal of Cancer.

[38]  R. Liggins,et al.  Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations. , 2002, Advanced drug delivery reviews.

[39]  Yan Zhao,et al.  RRR-alpha-tocopheryl succinate inhibits human gastric cancer SGC-7901 cell growth by inducing apoptosis and DNA synthesis arrest. , 2002, World journal of gastroenterology.

[40]  R. Coffey,et al.  Induction of cancer cell apoptosis by α‐tocopheryl succinate: molecular pathways and structural requirements , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  J. Neuzil,et al.  Selective cancer cell killing by α-tocopheryl succinate , 2001, British Journal of Cancer.

[42]  N. Boyd,et al.  Plasma lipids, lipoproteins, and familial breast cancer. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[43]  M. Umeda,et al.  Effect of lipid composition on HVJ-mediated fusion of glycophorin liposomes to erythrocytes. , 1985, Journal of biochemistry.

[44]  J. Leung.  Polymeric Micelles for Ocular Drug Delivery , 2018 .

[45]  U. Gupta,et al.  Polymeric Micelles: Recent Advancements in the Delivery of Anticancer Drugs , 2015, Pharmaceutical Research.

[46]  Xiangyang Shi,et al.  RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells. , 2015, Colloids and surfaces. B, Biointerfaces.

[47]  G. Helguera,et al.  Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®. , 2014, Colloids and surfaces. B, Biointerfaces.

[48]  T. Anchordoquy,et al.  In vivo comparative study of lipid/DNA complexes with different in vitro serum stability: effects on biodistribution and tumor accumulation. , 2008, Journal of pharmaceutical sciences.

[49]  So‐Hee Kim,et al.  Enhanced anticancer efficacy of alpha-tocopheryl succinate by conjugation with polyethylene glycol. , 2005, Journal of Controlled Release.

[50]  M. Freeman,et al.  Cholesterol and prostate cancer , 2004, Journal of cellular biochemistry.

[51]  Yanzhao,et al.  RRR—α—tocopheryl succinate inhibits human gastr cancer SGC—7901 cell growth by inducing apoptos and DNA synthesis arrest , 2002 .

[52]  J. Silverman,et al.  Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS). , 1999, Pharmaceutical research.

[53]  B. G. Sanders,et al.  RRR‐α‐tocopheryl succinate induces apoptosis in avian retrovirus‐transformed lymphoid cells , 1996 .

[54]  B. G. Sanders,et al.  RRR-alpha-tocopheryl succinate inhibits the proliferation of human prostatic tumor cells with defective cell cycle/differentiation pathways. , 1995, Nutrition and cancer.

[55]  B. G. Sanders,et al.  RRR-alpha-tocopheryl succinate inhibits proliferation and enhances secretion of transforming growth factor-beta (TGF-beta) by human breast cancer cells. , 1993, Nutrition and cancer.

[56]  B. G. Sanders,et al.  RRR‐α‐Tocopheryl succinate inhibits proliferation and enhances secretion of transforming growth factor‐β (TGF‐β) by human breast cancer cells , 1993 .